EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. – Neurocrine Biosciences, Inc. Transaction History
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:
$3.25M
portfolio value
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.07% | -2.69K shares | 4K | $106.21 | 30.66K |
| Q2 2022 | share | Increase | +7.33% | 2.27K shares | 338K | $97.48 | 33.36K |
| Q1 2022 | share | Increase | 0.00% | 31.08K shares | 2.91M | $93.75 | 31.08K |